126 related articles for article (PubMed ID: 32390266)
21. Responsiveness of Veterans Affairs Health Care System to Zolpidem Safety Warnings.
Kim HM; Gerlach LB; Yosef M; Stano C; Conroy DA; Valenstein M; Pfeiffer PN; Sales AE; Zivin K
J Clin Sleep Med; 2018 Jul; 14(7):1135-1141. PubMed ID: 29991420
[TBL] [Abstract][Full Text] [Related]
22. An Update on Fluoroquinolones: The Emergence of a Multisystem Toxicity Syndrome.
Tennyson LE; Averch TD
Urol Pract; 2017 Sep; 4(5):383-387. PubMed ID: 37592645
[TBL] [Abstract][Full Text] [Related]
23. Risk of retinal tear or detachment with oral fluoroquinolone use: a cohort study.
Eftekhari K; Ghodasra DH; Haynes K; Chen J; Kempen JH; VanderBeek BL
Pharmacoepidemiol Drug Saf; 2014 Jul; 23(7):745-52. PubMed ID: 24757075
[TBL] [Abstract][Full Text] [Related]
24. Healthcare costs and mortality associated with serious fluoroquinolone-related adverse reactions.
Kuula LSM; Backman JT; Blom ML
Pharmacol Res Perspect; 2022 Apr; 10(2):e00931. PubMed ID: 35170862
[TBL] [Abstract][Full Text] [Related]
25. Accuracy of identifying pediatric acute bacterial sinusitis diagnoses in outpatient claims data.
Savage TJ; Wardell H; Huybrechts KF
Pharmacoepidemiol Drug Saf; 2023 Aug; 32(8):918-923. PubMed ID: 36939079
[TBL] [Abstract][Full Text] [Related]
26. Levels of outpatient prescribing for four major antibiotic classes and rates of septicemia hospitalization in adults in different US states - a statistical analysis.
Goldstein E; Olesen SW; Karaca Z; Steiner CA; Viboud C; Lipsitch M
BMC Public Health; 2019 Aug; 19(1):1138. PubMed ID: 31426780
[TBL] [Abstract][Full Text] [Related]
27. Antimicrobial Stewardship in the Emergency Department.
Pulia M; Redwood R; May L
Emerg Med Clin North Am; 2018 Nov; 36(4):853-872. PubMed ID: 30297009
[TBL] [Abstract][Full Text] [Related]
28. Reducing Antibiotic Duration for Uncomplicated UTI in the Pediatric Emergency Department.
Kooner GK; Bass M; Saroha V; Gonzalez PJ; Jain S
Hosp Pediatr; 2024 Apr; 14(4):265-271. PubMed ID: 38533560
[TBL] [Abstract][Full Text] [Related]
29. Trends in antibiotic use in Massachusetts children, 2000-2009.
Greene SK; Kleinman KP; Lakoma MD; Rifas-Shiman SL; Lee GM; Huang SS; Finkelstein JA
Pediatrics; 2012 Jul; 130(1):15-22. PubMed ID: 22732172
[TBL] [Abstract][Full Text] [Related]
30. Analysis of the impact of antimicrobial management and rational use of antibiotics.
Yang J; Zheng L; Guan Y; Song C
Eur J Hosp Pharm; 2020 Sep; 27(5):286-291. PubMed ID: 32839261
[TBL] [Abstract][Full Text] [Related]
31. Current progress of fluoroquinolones-increased risk of aortic aneurysm and dissection.
Jun C; Fang B
BMC Cardiovasc Disord; 2021 Sep; 21(1):470. PubMed ID: 34583637
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic antibiotic use patterns in dogs: observations from a veterinary teaching hospital.
Wayne A; McCarthy R; Lindenmayer J
J Small Anim Pract; 2011 Jun; 52(6):310-8. PubMed ID: 21627659
[TBL] [Abstract][Full Text] [Related]
33. Safety Concerns Surrounding Quinolone Use in Children.
Patel K; Goldman JL
J Clin Pharmacol; 2016 Sep; 56(9):1060-75. PubMed ID: 26865283
[TBL] [Abstract][Full Text] [Related]
34. Characterizing Trends in Diagnosis and Management of Sinusitis in a Large Health Care System: From Primary Care to Otolaryngology.
Hornung CM; Ganti A; Lunos S; Tyler MA
Ann Otol Rhinol Laryngol; 2024 May; 133(5):476-484. PubMed ID: 38345045
[TBL] [Abstract][Full Text] [Related]
35. Should patients with acute exacerbation of chronic bronchitis be treated with antibiotics? Advantages of the use of fluoroquinolones.
Mensa J; Trilla A
Clin Microbiol Infect; 2006 May; 12 Suppl 3(Suppl 3):42-54. PubMed ID: 16669928
[TBL] [Abstract][Full Text] [Related]
36. An evaluation of reports of ciprofloxacin, levofloxacin, and moxifloxacin-association neuropsychiatric toxicities, long-term disability, and aortic aneurysms/dissections disseminated by the Food and Drug Administration and the European Medicines Agency.
Bennett AC; Bennett CL; Witherspoon BJ; Knopf KB
Expert Opin Drug Saf; 2019 Nov; 18(11):1055-1063. PubMed ID: 31500468
[No Abstract] [Full Text] [Related]
37. Stronger Boxed Warning for Benzodiazepines.
Aschenbrenner DS
Am J Nurs; 2021 Mar; 121(3):22-23. PubMed ID: 33625005
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of healthcare professionals' understanding of fluoroquinolones' safety profile, usage, and boxed warnings in Pakistan.
Abbas M; Kashmiri K; Rehman IU; Ali Z; Rahman AU; Khalil A; Ming LC; Shafique M; Khan TM
J Pharm Policy Pract; 2023 Nov; 16(1):154. PubMed ID: 38012805
[TBL] [Abstract][Full Text] [Related]
39. FDA Adds Boxed Warning to CAR T-Cell Therapies, but Says Benefits Outweigh Risks of Secondary Cancers.
Suran M
JAMA; 2024 Mar; 331(10):818-820. PubMed ID: 38381427
[TBL] [Abstract][Full Text] [Related]
40. Fluoroquinolone resistance in urinary tract infections: Epidemiology, mechanisms of action and management strategies.
Thompson D; Xu J; Ischia J; Bolton D
BJUI Compass; 2024 Jan; 5(1):5-11. PubMed ID: 38179021
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
